| SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance H Yang, H Shen, J Li, LW Guo Autophagy 15 (9), 1539-1557, 2019 | 64 | 2019 |
| Bispecific antibodies in cancer immunotherapy S Chen, J Li, Q Li, Z Wang Human vaccines & immunotherapeutics 12 (10), 2491-2500, 2016 | 59 | 2016 |
| Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes S Kumar, R Javed, M Mudd, S Pallikkuth, KA Lidke, A Jain, K Tangavelou, ... Cell 184 (24), 5950-5969. e22, 2021 | 58 | 2021 |
| Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells Y Li, C Zhou, J Li, J Liu, L Lin, L Li, D Cao, Q Li, Z Wang PloS one 13 (1), e0191024, 2018 | 40 | 2018 |
| A novel bispecific antibody, BiSS, with potent anti-cancer activities B Dong, C Zhou, P He, J Li, S Chen, J Miao, Q Li, Z Wang Cancer biology & therapy 17 (4), 364-370, 2016 | 33 | 2016 |
| Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity J Li, C Zhou, B Dong, H Zhong, S Chen, Q Li, Z Wang Cancer Biology & Therapy 17 (12), 1231-1239, 2016 | 32 | 2016 |
| A novel bispecific antibody, S-Fab, induces potent cancer cell killing L Li, P He, C Zhou, L Jing, B Dong, S Chen, N Zhang, Y Liu, J Miao, ... Journal of Immunotherapy 38 (9), 350-356, 2015 | 30 | 2015 |
| BiHC, a T-cell–engaging bispecific recombinant antibody, has potent cytotoxic activity against Her2 tumor cells J Xing, L Lin, J Li, J Liu, C Zhou, H Pan, R Shu, B Dong, D Cao, Q Li, ... Translational Oncology 10 (5), 780-785, 2017 | 20 | 2017 |
| A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity L Lin, L Li, C Zhou, J Li, J Liu, R Shu, B Dong, Q Li, Z Wang Oncology letters 16 (1), 1259-1266, 2018 | 16 | 2018 |
| BRD2 regulation of sigma-2 receptor upon cholesterol deprivation H Shen, J Li, X Xie, H Yang, M Zhang, B Wang, KC Kent, J Plutzky, ... Life Science Alliance 4 (1), 2021 | 15 | 2021 |
| A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasis C Zhou, J Li, L Lin, R Shu, B Dong, D Cao, Q Li, Z Wang Oncotarget 9 (33), 23102, 2018 | 13 | 2018 |
| Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia Y Huang, G Urabe, M Zhang, J Li, HG Ozer, B Wang, KC Kent, LW Guo Atherosclerosis 308, 22-31, 2020 | 12 | 2020 |
| SREBP1 regulates Lgals3 activation in response to cholesterol loading J Li, H Shen, GK Owens, LW Guo Molecular Therapy-Nucleic Acids 28, 892-909, 2022 | 9 | 2022 |
| TMEM97 ablation aggravates oxidant-induced retinal degeneration H Shen, J Li, T Heisler-Taylor, R Makin, H Yang, TA Mavlyutov, B Gelfand, ... Cellular signalling 86, 110078, 2021 | 8 | 2021 |
| A role for polo-like kinase 4 in vascular fibroblast cell-type transition J Li, G Urabe, Y Huang, M Zhang, B Wang, L Marcho, H Shen, KC Kent, ... Basic to Translational Science 6 (3), 257-283, 2021 | 8 | 2021 |
| Angioplasty induces epigenomic remodeling in injured arteries M Zhang, G Urabe, HG Ozer, X Xie, A Webb, T Shirasu, J Li, R Han, ... Life Science Alliance 5 (5), 2022 | 6 | 2022 |
| Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts H Yang, H Shen, J Li, KI Stanford, LW Guo Cellular signalling 75, 109732, 2020 | 6 | 2020 |
| Differential responses to sigma-1 or sigma-2 receptor ablation in adiposity, fat oxidation, and sexual dimorphism J Li, E Félix-Soriano, KR Wright, H Shen, LA Baer, KI Stanford, LW Guo International journal of molecular sciences 23 (18), 10846, 2022 | 5 | 2022 |
| Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation M Zhang, J Li, Q Wang, G Urabe, R Tang, Y Huang, JV Mosquera, ... Molecular Therapy-Nucleic Acids 31, 717-729, 2023 | 2 | 2023 |
| miR579-3p is an inhibitory modulator of neointimal hyperplasia and transcription factors c-MYB and KLF4 X Xie, T Shirasu, J Li, LW Guo, KC Kent Cell Death Discovery 9 (1), 73, 2023 | 2 | 2023 |
